John J. TALLEY,Bobby W. SANDAGE, JR.,Eduardo J. MARTINEZ
申请号：
US15401777
公开号：
US20170196835A1
申请日:
2017.01.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present disclosure provide a combination of a chromene compound having the structure of Formula (I), or pharmaceutically acceptable salts, and a second compound that can be selected from a PD-1 inhibitor, PD-L1 inhibitor, CTLA-4 inhibitor, OX-40 agonist, CD137 agonist, LAG-3 inhibitor, IDO inhibitor, bi-specific protein, EGFR inhibitor, HER2 inhibitor, and immune stimulating therapy and a method of using the combination for treating or preventing cancer.
